Evidence map›Paper›PMID 23775841›Full record

ArticlePediatric pulmonology2014

Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.

A H Gifford, A B Nymon, A Ashare

Abstract read
In one paragraph

Article in Pediatric pulmonology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Endocrine Complications of Cystic Fibrosis.Clinics in chest medicine · 2022
    Review
  3. Cystic fibrosis related liver disease and endocrine considerations.Journal of clinical & translational endocrinology · 2022
    Article
  4. Article
  5. Article
  6. Serum insulin-like growth factor-1, asthma, and lung function among British adults.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Article
  7. Review
  8. GH-IGF-1 Axis in Children with Cystic Fibrosis.Clinical medicine & research · 2019
    Article
  9. Review
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A H GiffordPulmonary and Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Dartmouth Lung Biology Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
A B Nymon
A Ashare
Dartmouth College · USDartmouth–Hitchcock Medical Center · US

Funding

SYNERGY: The Dartmouth Center for clinical and Translational ScienceKL2TR001088 · NCATS · DARTMOUTH COLLEGE · PI GREEN, ALAN I · 2013 to 2017
$3.3M
Cellular and Molecular Mechanisms of Lung DiseaseP20GM103413 · NIGMS · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2012 to 2012
$2.1M
NCATS NIH HHS KL2 TR001088NIGMS NIH HHS 8P20GM103413-10NIGMS NIH HHS P20 GM103413
6 · The paper itself

Abstract

introductionCystic fibrosis (CF) is characterized by low circulating levels of insulin-like growth factor-1 (IGF-1), a hormone produced by the liver that governs anabolism and influences immune cell function. Because treatment of CF pulmonary exacerbation (CFPE) often improves body weight and lung function, we questioned whether serum IGF-1 trends were emblematic of these responses. Initially, we compared serum levels between healthy adults with CF and controls of similar age. We then measured serum IGF-1 throughout the CFPE cycle. We also investigated correlations among IGF-1 and other serum biomarkers during CFPE.

methodsAnthopometric, spirometric, and demographic data were collected. Serum IGF-1 concentrations were measured by ELISA.

resultsCF subjects in their usual state of health had lower serum IGF-1 levels than controls. Serum IGF-1 concentrations fell significantly from baseline at the beginning of CFPE. Treatment with intravenous antibiotics was associated with significant improvement in serum IGF-1 levels, body mass index (BMI), and percent-predicted forced expiratory volume in 1 sec (FEV1 %). At early and late CFPE, serum IGF-1 was directly correlated with FEV1 %, serum iron, hemoglobin concentration, and transferrin saturation (TSAT) and indirectly correlated with alpha-1-antitrypsin.

conclusionsThis study not only supports the paradigm that CF is characterized by IGF-1 deficiency but also that trends in lung function, nutritional status, and serum IGF-1 are related. Improvements in all three parameters after antibiotics for CFPE likely highlight the connection between lung function and nutritional status in CF. Close correlations among IGF-1 and iron-related hematologic parameters suggest that IGF-1 may participate in CF iron homeostasis, another process that is known to be influenced by CFPE.

Indexed as

Disease ProgressionAdolescentAdultBiomarkersCystic FibrosisFemaleHumansInsulin-Like Growth Factor IMaleMiddle AgedYoung AdultBiomarkersInsulin-Like Growth Factor Icystic fibrosisexacerbationFEV1IGF-1iron

Identifiers

PMID23775841
PMCPMC4709121
OpenAlexW1758686867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.